XChange TEC.INC American Depositary Shares (XHG)
FairStock Score: 20/100 — RISKY
Key Financials
| Current Price | $3.79 |
| Market Cap | $53M |
| P/E Ratio | 0.04 |
| ROE | —% |
| Dividend Yield | 0% |
| Sector | Financial Services |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
I prefer businesses with durable competitive advantages, consistent earnings, and clean balance sheets. XChange TEC is a tiny insurance agency and insurance technology company with a $52.6M market cap and only 30 employees, operating in China and Hong Kong. The supplied numbers are not inviting. Return on capital employed is -20.09% (FairStock calculation), the Piotroski F-Score is 1/9, and the Altman Z-Score is -115.95, which point to weak financial health and high distress risk. The P/E is 0.02 (FairStock calculation at the 2026-10-13 close of $1.97), but that is so far below normal that I would treat it as a data artifact rather than a margin of safety. The FairStock Score is 20/100. No dividend is paid. The Lynch category is 'none' because only 0 year(s) of filed results exist, so I cannot judge consistency. Revenue growth and profit growth are N/A, leaving no evidence of expanding economics. The 52-week range of $0.65 to $7.23 shows how speculative the price has been, and a beta of -0.40 does not substitute for fundamental stability. An insurance brokerage can be capital-light, but scale matters, and with 30 employees I cannot identify a moat from the data provided. Graham would ask for earnings stability, net current asset value, and interest coverage; those are not provided. Buffett would ask for predictable economics and honest management; I see neither proven here. The stock may look statistically cheap on one distorted multiple, but the qualitative and financial record do not support a value conclusion. I would need several years of filed results before treating this as an investment rather than a speculation.
In plain English: XChange TEC is a small insurance agency and insurance technology company serving customers in China and Hong Kong. The business looks weak on the numbers provided: it is not earning a positive return on the money it uses, and its financial-health marks are poor. The price may look very cheap based on one earnings measure, but there is not enough filed history or stable profit data to call it a safe bargain.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash
Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer